Identification, fermentation, and bioactivity against xanthomonas oryzae of antimicrobial metabolites isolated from phomopsis longicolla S1B4

Journal of Microbiology and Biotechnology

Volumn 20, Issue 3, 2010, Pages 494-500

  Lim, Chaesung ^a   Kim, Jiyoung ^a   Choi, Jung Nam ^a   Ponnusamy, Kannan ^a   Jeon, Yultaek ^b   Kim, Soo Un ^b   Kim, Jeong Gu ^c   Lee, Choong Hwan ^a  

^a Konkuk University   (South Korea)

^b Seoul National University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

Antibacterial activity; Fusaristatin A; Phomopsis longicolla; Xanthomonas oryzae

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIINFECTIVE AGENT; DEACETYLPHOMOXANTHONE B; DICERANDROL A; DICERANDROL B; DICERANDROL C; DRUG METABOLITE; FUSARISTATIN A; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG TARGETING; FERMENTATION; FRACTIONATION; FUNGUS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MYCELIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOMOPSIS LONGICOLLA; SOLVENT EXTRACTION; XANTHOMONAS; XANTHOMONAS ORYZAE;

ANTI-INFECTIVE AGENTS; ASCOMYCOTA; FERMENTATION; MICROBIAL SENSITIVITY TESTS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET; XANTHOMONAS;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; PHOMOPSIS; PHOMOPSIS LONGICOLLA; STAPHYLOCOCCUS AUREUS; XANTHOMONAS ORYZAE;

EID: 77954296917     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Akihiro, K., K. Fumihisa, M. Godliving, and N. Yoshitoshi. 2006. Development of optimal culture method of Sparassis crispa mycelia and a new extraction method of antineoplastic constituent. Biochem. Eng. J. 30: 109-113.
2. Casas López, J. L., J. A. Sánchez Pérez, J. M. Fernández Sevilla, F. G. Acién Fernández, E. Molina Grima, and Y. Chisti. 2003. Production of lovastatin by Aspergillus terreus: Effects of the C:N ratio and the principal nutrients on growth and metabolite production. Enzyme Microb. Tech. 33: 270-277.
3. Cui, C. B., M. Ubukata, H. Kakeya, R. Onose, G. Okada, I. Takahashi, K. Isono, and H. Osada. 1996. Acetophthalidin, a novel inhibitor of mammalian cell cycle, produced by a fungus isolated from a sea sediment. J. Antibiot. (Tokyo) 49: 216-219.
4. Dung, N. T., J. M. Kim, and S. C. Kang. 2008. Chemical composition, antimicrobial and antioxidant activities of the essential oil and the ethanol extract of Cleistocalyx operculatus (Roxb.) Merr and Perry buds. Food Chem. Toxicol. 46: 3632-3639.
5. Espinel-Ingroff, A., B. Arthington-Skaggs, N. Iqbal, D. Ellis, M. A. Pfaller, S. Messer, et al. 2007. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J. Clin. Microbiol. 45: 1811-1820.
6. Goker, H., S. Ozden, S. Yildiz, and D. W. Boykin. 2005. Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines. Eur. J. Med. Chem. 40: 1062-1069.
7. György, S., M. György, and P. T. Robert. 1998. Production of lovastatin by a wild strain of Aspergillus terreus. Biotechnol. Lett. 20: 411-415.
8. Lee, C. H., H. J. Kempt, Y. Lim, and Y. H. Cho. 2000. Biocontrol activity of Pseudomonas cepacia AF2001 and anthelmintic activity of its novel metabolite, Cepacidine A. J. Microbiol. Biotechnol. 10: 568-571.
9. Lee, S. B., K. H. Cha, S. N. Kim, S. Altantsetseg, S. Shatar, O. Sarangerel, and C. W. Nho. 2007. The antimicrobial activity of essential oil from Dracocephalum foetidum against pathogenic microorganisms. J. Microbiol. 45: 53-57.
10. Mikani, A., H. R. Etebarian, P. L. Sholberg, D. T. O'Gorman, S. Stokes, and A. Alizadeh. 2008. Biological control of apple gray mold caused by Botrytis mali with Pseudomonas fluorescens strains. Postharvest Biol. Tech. 48: 107-112.
11. Rukachaisirikul, V., U. Sommart, S. Phongpaichit, J. Sakayaroj, and K. Kirtikara. 2008. Metabolites from the endophytic fungus Phomopsis sp. PSU-D15. Phytochemistry 69: 783-787.
12. Shiono, Y., M. Tsuchinari, K. Shimanuki, T. Miyajima, T. Murayama, T. Koseki, et al. 2007. Fusaristatins A and B, two new cyclic lipopeptides from an endophytic Fusarium sp. J. Antibiot. (Tokyo) 60: 309-316.
13. Tsuge, S., H. Ochiai, Y. Inoue, T. Oku, K. Tsuno, H. Kaku, and Y. Kubo. 2004. Involvement of phosphoglucose isomerase in pathogenicity of Xanthomonas oryzae pv. oryzae. Phytopathology 94: 478-483.
14. Tsumagari, N., R. Nakai, H. Onodera, A. Hasegawa, E. S. Rahayu, K. Ando, and Y. Yamashita. 2004. MPC1001, a new antitumor antibiotic produced by Cladorrhinum sp. J. Antibiot. (Tokyo) 57: 532-534.
15. Velusamy, P., J. E. Immanuel, S. S. Gnanamanickam, and L. Thomashow. 2006. Biological control of rice bacterial blight by plant-associated bacteria producing 2,4-diacetylphloroglucinol. Can. J. Microbiol. 52: 56-65.
16. Wagenaar, M. M. and J. Clardy. 2001. Dicerandrols, new antibiotic and cytotoxic dimers produced by the fungus Phomopsis longicolla isolated from an endangered mint. J. Nat. Prod. 64: 1006-1009.
17. Zhu, Z. J., O. Krasnykh, D. Pan, V. Petukhova, G. Yu, Y. Liu, et al. 2008. Structure-activity relationships of macrolides against Mycobacterium tuberculosis. Tuberculosis (Edinb.) 88: 49-63.